| Helen Joseph, | |
|
82 Wendell Ave Ste 100, Pittsfield, MA 01201-7066 | |
| (617) 410-6494 | |
| Not Available |
| Full Name | Helen Joseph |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 82 Wendell Ave Ste 100, Pittsfield, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003336504 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Helen Joseph, 16 Bolster St # 2, Everett, MA 02149-1617 Ph: () - | Helen Joseph, 82 Wendell Ave Ste 100, Pittsfield, MA 01201-7066 Ph: (617) 410-6494 |
News Archive
Roll Call reports that the Administration's alliances with major health organizations may not be as strong as previously thought. "An analysis of these groups' positions suggests few are completely on board and several may oppose the president in the end.
Benznidazole is one of the two existing antiparasitic drugs for Chagas' disease treatment. However, it is a poorly tolerated drug and its use to treat chronic disease raises safety concerns. Knowledge about its toxicity profile is scarce and mostly based on post-marketing observational studies.
A team of investigators at the University of Kentucky has made a thought-provoking discovery about a type of cholesterol previously believed to be a "bad guy" in the development of heart disease and other conditions.
Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind. Researchers also reported that an engineered protein restored vision in an animal model and identified ways to improve stem cell treatments.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
› Verified 7 days ago
Eileeen Morrison, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-629-1262 Fax: 413-448-2198 | |
Jill Marion, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-629-1262 Fax: 413-448-2198 | |
Ms. Pamela Bucklin Burger, Counselor Medicare: Not Enrolled in Medicare Practice Location: 53 Eagle St, First Floor, Pittsfield, MA 01201 Phone: 413-236-5656 Fax: 413-499-6572 | |
Daniel Sullivan, Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-629-1251 Fax: 413-448-2198 | |
Theresa Whitney, Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-629-1262 Fax: 413-448-2198 | |
Quintin Sumpter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 Fenn St, Administrative Offices, Pittsfield, MA 01201 Phone: 413-629-1262 Fax: 413-448-2198 |